Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Arthur Bristol currently holds 29,888 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Arthur Bristol has been a net seller of DCPH stock. They have purchased $82.8K and sold $9.1M worth of shares.
James Arthur Bristol's most recent insider trade was on Jun 26, 2026, when they sold 29,888 shares at $0.00 per share.
James Arthur Bristol serves as Executive at Deciphera Pharmaceuticals, Inc. (DCPH). They have executed 65 insider transactions totaling $9.2M over their tenure at the company.
James Arthur Bristol holds the position of Executive at Deciphera Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
James Arthur Bristol has shown a selling trading pattern, with $82.8K in total purchases and $9.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James Arthur Bristol was on Nov 1, 2019, when they sold $1.1M worth of DCPH shares. This transaction involved 25,000 shares at $45.07 per share.
James Arthur Bristol currently owns 29,888 shares of Deciphera Pharmaceuticals, Inc. (DCPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Arthur Bristol's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Arthur Bristol has 65 Form 4 filings on record as an insider at Deciphera Pharmaceuticals, Inc..
Set alerts for James Arthur Bristol and 40,000+ other insiders.